B cell-specific mab-sirna conjugates improve myasthenia

Abstract

The present invention relates to a combination of two antibody-RNA conjugates comprising an anti-BAFF receptor antibody or binding fragment thereof that is bound or conjugated to a small RNA that targets a BAFF receptor mRNA, and an anti-BCMA specific antibody or binding fragment thereof that is …